Navigation Links
diaDexus, Inc. Reports 2010 Third Quarter Financial Results
Date:11/15/2010

6619,059,144DIADEXUS, INC.CONDENSED CONSOLIDATED BALANCE SHEETS(In thousands, except share data)September 30,
2010December 31,
2009(unaudited)AssetsCurrent assets:Cash and cash equivalents$

23,238$

2,539Short-term investment securities—2,262Accounts receivable 1,2651,637Receivable from related party196295Inventories106221Restricted cash400—Assets held for sale310—Prepaid expenses and other current assets1,155618Total current assets26,6707,572Restricted cash1,400400Property and equipment, net7841,366Other long-term assets3130Total assets$

28,857$

9,468Liabilities, Convertible Preferred Stock and Stockholders' Equity (Deficit)Current liabilities:Accounts payable$

736$

273Notes payable—3,498Deferred revenues, current portion344318Deferred rent, current portion156194Unfavorable lease obligations383—Accrued and other current liabilities1,7471,922Total current liabilities3,3666,205Long-term deferred rent—103Non-current portion of unfavorable lease obligation3,649—Non-current portion of deferred revenue9121,140Warrant liability—36Other long term liabilities1,058—Total liabilities8,9857,484Commitments and contingenciesConvertible preferred stock—168,242Stockholders' equity (deficit):Common stock53118Additional paid-in capital204,71412,739Accumulated deficit (185,373)(179,015)Total stockholders' equity (deficit)19,872(166,258)Total liabilities, convertible preferred stock and stockholders' equity (deficit)$

28,857$

9,468*

The balance sheet at December 31, 2009 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements.
'/>"/>

SOURCE diaDexus, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. diaDexus, Inc. Adds Two New Directors; Corporate Overview & 3Q Results Webcast Set for November 16, 2010
2. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
3. Spherix Reports Second Quarter Earnings
4. Tapestry Reports Second Quarter 2007 Results
5. Callisto Reports on Second-Quarter 2007 Milestones
6. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
7. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
8. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
9. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
10. Biopure Reports on Meeting with the FDA
11. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... , Sept. 1, 2015  Valeant Pharmaceuticals International, ... today announced that its affiliate has entered into ... was granted an exclusive license to develop and ... IL-17 receptor monoclonal antibody in development for patients ... the agreement, Valeant will hold the exclusive rights ...
(Date:8/31/2015)... , Aug. 31, 2015 Pepperl+Fuchs, a ... acquired MACTek Corporation, a leading provider of HART ... strategy to further extend its integrated solutions offerings ...   "We are pleased to add ... portfolio," said Jim Bolin , Pepperl+Fuchs, executive ...
(Date:8/31/2015)... , Aug. 31, 2015 Thousands of people ... neglect of the opioid addiction epidemic at dozens of ... term in 2008, the United States ... addiction involving prescription opioids and heroin, yet the President ... a strongly worded letter to President Obama , ...
Breaking Medicine Technology:Valeant And AstraZeneca To Partner On Brodalumab 2Valeant And AstraZeneca To Partner On Brodalumab 3Valeant And AstraZeneca To Partner On Brodalumab 4Obama Administration's Neglect of Opioid Crisis Prompts Rallies in Many States 2
... Sept. 7 Epeius Biotechnologies Corporation, a leader in ... publication of a landmark paper in clinical oncology. Following ... of Rexin-G in chemo-resistant metastatic pancreatic cancer ( Molecular ... Drug and FDA Fast Track Status, this new paper ...
... India, Sept. 7 Sun Pharmaceutical Industries Ltd. (Sun) ... today announced that the Supreme Court of Israel has ... (Taro) (Pink Sheets: TAROF ) of the ... the Israeli special tender offer (STO) rules do not ...
Cached Medicine Technology:To Reach, Perchance to Kill the Cancer: A Soliloquy From Epeius Nanotechnologies Opposes That 'Sea of Troubles' 2Supreme Court of Israel Rules in Favor of Sun Pharma 2Supreme Court of Israel Rules in Favor of Sun Pharma 3
(Date:9/1/2015)... ... September 01, 2015 , ... ... prevent different malignancies. Some options for cancer treatment are available belonging to ... distinctive approach is necessary for effective treatment. Several molecules have been discovered ...
(Date:9/1/2015)... ... September 01, 2015 , ... Virginia entrepreneur Marcella Ellis, ... strongly maintaining her firm’s success in the hair care and distribution industry through ... tour, Ellis will be providing “Look and learn” live demonstrations, as well as ...
(Date:9/1/2015)... , ... September 01, 2015 , ... ... monitoring and analysis of pet vital signs and activity, today announced its integration ... of the most popular and widely-adopted veterinary hospital Practice Management Software packages in ...
(Date:9/1/2015)... ... September 01, 2015 , ... Zecurion, a leading developer of data loss ... version of endpoint DLP developed specifically for Mac OS. , In June 2015, the ... IT and information security professionals had participated. The beta test done by the developer ...
(Date:9/1/2015)... ... 2015 , ... SC&H Group, a leading audit, tax, and consulting firm, received ... the Best” firm in the U.S., as well as being ranked a Top 100 ... the U.S., selected exclusively on performance in specific areas of financial and operational management. ...
Breaking Medicine News(10 mins):Health News:CD Antigen Cancer Market and Pipeline Landscape Examined in Comprehensive Kuick Research Report Published at MarketPublishers.com 2Health News:CD Antigen Cancer Market and Pipeline Landscape Examined in Comprehensive Kuick Research Report Published at MarketPublishers.com 3Health News:Beauty Entrepreneur creates hair extension smart machine and mobile app inspired by UBER technology 2Health News:Petpace-Cornerstone Integration Lowers Overhead, Raises Data Visibility for Veterinary Practices 2Health News:Zecurion Announces Endpoint Security for Mac 2Health News:SC&H Group Receives Multiple Honors from INSIDE Public Accounting 2
... approved a gel that promises less internal scarring ... initially rejected Lifecore Biomedical Inc.'s Intergel, which promises ... // ,The gel, formally named Gynecare ... adhesions, internal scar tissue that can cause chronic ...
... protein released by damaged heart tissue may be a helpful ... Performing heart bypass surgery or angioplasty on patients with elevated ... estimated 40 percent. ,// ,"Any sign of heart ... amount, was a sign that the patient was at high ...
... and aspirin are equally effective in stroke prevention in the ... stopping platelets from clumping together, while warfarin acts on the ... help prevent blood clots in the brain that lead to ... more effective at preventing stroke, but causes more side effects ...
... similar impact on the body to the ageing process ... such as heart disease and diabetes, researchers have found. ... asleep per night in more developed countries has decreased ... been made to accommodate increased demands of work and ...
... the first time, the US Food and Drug Administration (FDA) ... Evra, made by New Jersey-based Johnson & Johnson, is a ... to be an alternative to birth control pills. // ... a 1-week period. Ortho Evra can be worn on the ...
... have recently found a way of creating brain cells out ... grafts for Parkinson's disease. At the Peterson Medical College scientists ... cocktail of growth factors and other chemicals and found they ... such stem cells form muscle, bone, cartilage and fat. The ...
Cached Medicine News:Health News:Deprived sleep leads to ageing 2
Delicate Desmarres lid retractors, round serrated handle, very thin blades, polished finish, size 1....
Desmarres Lid Retractor thin solid blades. Size 2....
The Storz Protege is an anterior segment unit only....
... all the features of phaco systems costing ... minimal maintenance. Small, light and tough enough ... Lowest cost reusable tubing kit can be ... there a price objection to purchasing a ...
Medicine Products: